Onconetix Inc (ONCO) Stock Price, Quote & News

Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the Panc...

Industry: Biotechnology

Sector: Healthcare

Phone: 513 620 4101

Website: www.onconetix.com

Address:

201 East Fifth Street, Suite 1900, Cincinnati, United States

drweinerdog1 Jul. 20 at 2:28 PM

$ONCO congrats everyone on another all time low

0 · Reply

drweinerdog1 Jul. 20 at 2:14 PM

$ONCO how much dilution this week

0 · Reply

Sarah147 Jul. 20 at 10:59 AM

$ONCO clean ticker

1 · Reply

URANIUM77 Jul. 20 at 9:44 AM

$ONCO There is no dilution The company still has only 3.69M shares https://dilutiontracker.com/app/search/ONCO

0 · Reply

drweinerdog1 Jul. 17 at 9:34 PM

$ONCO wow no dilution on a Friday, good job guys, you guys did so good.

0 · Reply

drweinerdog1 Jul. 17 at 3:51 PM

$ONCO the scam that keeps scamming

0 · Reply

URANIUM77 Jul. 17 at 1:48 PM

$ONCO If we get 10% of Realbotix, it equates to 10 times the current share price for us ONCO shareholders. Mega BULL

1 · Reply

URANIUM77 Jul. 17 at 12:41 PM

$ONCO 👊There are no real sellers left anymore. Only short positions remain in the free float. No one is giving away their shares anymore.💪

2 · Reply

URANIUM77 Jul. 17 at 8:33 AM

$ONCO Robotics stocks are considered strong, long-term investments, backed by a projected sector growth from $76 billion to over $218 billion by 2030. Driven by breakthroughs in artificial intelligence (AI), companies specializing in physical automation are scaling rapidly.

1 · Reply

drweinerdog1 Jul. 16 at 10:45 PM

$ONCO where did the other pumper go, or maybe he blocked me

0 · Reply

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

Jun 24, 2026, 8:30 AM EDT - 26 days ago

Onconetix Highlights Realbotix's Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District

Jun 19, 2026, 7:00 PM EDT - 4 weeks ago

Onco-Innovations Announces Non-Brokered LIFE Offering

Jun 19, 2026, 6:00 PM EDT - 4 weeks ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

Jun 16, 2026, 6:00 PM EDT - 4 weeks ago

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

Jun 9, 2026, 8:00 AM EDT - 5 weeks ago

Onconetix Registration statement: Registration filing

2026-06-09T10:06:30.000Z - 5 weeks ago

Onconetix files to sell 100M shares of common stock for holders

2026-05-20T23:50:10.000Z - 2 months ago

Onconetix Inc trading halted, news pending

2026-05-19T12:39:58.000Z - 2 months ago

Onconetix announces 1-for-10 reverse stock split

May 19, 2026, 8:00 AM EDT - 2 months ago

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

2026-05-19T11:47:20.000Z - 2 months ago

Realbotix expects transaction with Onconetix to close by October

May 19, 2026, 7:30 AM EDT - 2 months ago

Realbotix Provides Update on Nasdaq Listing

May 13, 2026, 9:25 AM EDT - 2 months ago

Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

May 13, 2026, 7:00 AM EDT - 2 months ago

Onconetix Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 2 months ago

Onconetix Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 2 months ago

Onconetix Registration statement: Registration filing

2026-04-28T20:18:54.000Z - 2 months ago

Onconetix files to sell 25M shares of common stock for holders

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Onconetix Registration statement: Registration filing

Apr 9, 2026, 8:30 AM EDT - 3 months ago

Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson

Apr 2, 2026, 8:30 AM EDT - 3 months ago

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

2026-03-31T13:13:26.000Z - 3 months ago

Onconetix CEO Karina Fedasz to step down, David White to succeed

ARTW

Mar 31, 2026, 8:30 AM EDT - 3 months ago

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Mar 30, 2026, 8:00 AM EDT - 4 months ago

Onconetix Proxy statement: Proxy filing

Mar 25, 2026, 12:47 PM EDT - 4 months ago

Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration

2026-03-24T23:50:18.000Z - 4 months ago

Onconetix Inc trading halted, news pending

2026-03-23T13:12:26.000Z - 4 months ago

Onconetix announces 1-for-5 reverse stock split

Mar 23, 2026, 8:30 AM EDT - 4 months ago

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Mar 18, 2026, 8:00 AM EDT - 4 months ago

Onconetix Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 4 months ago

Onconetix Annual report: Q4 2025

2026-02-12T13:27:43.000Z - 5 months ago

Onconetix to acquire Realbotix LLC in all-stock transaction

Feb 12, 2026, 8:00 AM EST - 5 months ago

Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company

Feb 12, 2026, 8:00 AM EST - 5 months ago

Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Jan 2, 2026, 7:00 AM EST - 7 months ago

Onconetix Proxy statement: Proxy Filing

Dec 22, 2025, 7:00 AM EST - 7 months ago

Onconetix Registration statement: Registration Filing

Dec 22, 2025, 7:00 AM EST - 7 months ago

Onconetix Proxy statement: Proxy Filing

Nov 10, 2025, 7:00 AM EST - 9 months ago

Onconetix Proxy statement: Proxy Filing

2025-11-04T21:45:43.000Z - 9 months ago

Onconetix files to sell 22.07M shares of common stock for holders

Nov 4, 2025, 7:00 AM EST - 9 months ago

Onconetix Registration statement: Registration Filing

Oct 29, 2025, 8:00 AM EDT - 9 months ago

Onconetix Proxy statement: Proxy Filing

Oct 16, 2025, 8:00 AM EDT - 9 months ago

Onconetix Registration statement: Registration Filing

2025-10-16T10:10:38.000Z - 9 months ago

Onconetix files to sell 5.1M shares of common stock for holders

2025-09-26T12:40:45.000Z - 10 months ago

Onconetix announces financing through private placement, debt settlement

VERU

Sep 26, 2025, 8:30 AM EDT - 10 months ago

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

2025-09-26T12:20:26.000Z - 10 months ago

Onconetix, Ocuvex announce mutual termination of merger agreement

Sep 26, 2025, 8:15 AM EDT - 10 months ago

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

2025-09-22T12:10:57.000Z - 10 months ago

Onconetix’s Proteomedix licenses manufacturing IP to Immunovia

Sep 22, 2025, 8:00 AM EDT - 10 months ago

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

2025-07-16T12:21:02.000Z - 1 year ago

Onconetix, Ocuvex execute definitive merger agreement

Jul 16, 2025, 8:17 AM EDT - 1 year ago

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

2025-06-16T12:25:20.000Z - 1 year ago

Onconetix receives positive decision by Nasdaq Hearings Panel

Jun 16, 2025, 8:22 AM EDT - 1 year ago

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

2025-06-12T23:50:23.000Z - 1 year ago

Onconetix Inc trading halted, news pending

2025-06-11T15:35:06.000Z - 1 year ago

Onconetix announces 1-for-85 reverse stock split

Jun 11, 2025, 11:30 AM EDT - 1 year ago

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

May 22, 2025, 4:50 PM EDT - 1 year ago

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

May 22, 2025, 10:00 AM EDT - 1 year ago

Onco-Innovations Uplists to Cboe Canada

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Mar 24, 2025, 8:45 AM EDT - 1 year ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Feb 7, 2025, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Jan 27, 2025, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Dec 12, 2024, 5:00 PM EST - 1 year ago

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Dec 11, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Dec 10, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Onconetix Registration statement: Registration Filing

Oct 8, 2024, 5:00 AM EDT - 1 year ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

OCS VRNA GRDX

Oct 3, 2024, 4:45 PM EDT - 1 year ago

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 9:05 AM EDT - 1 year ago

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Sep 20, 2024, 11:45 AM EDT - 1 year ago

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Sep 3, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Aug 1, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Jul 22, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Jul 15, 2024, 6:00 AM EDT - 2 years ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Jul 11, 2024, 8:17 AM EDT - 2 years ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Jun 5, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Jun 5, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

Onconetix Registration statement: Registration Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

Onconetix Proxy statement: Proxy Filing

Feb 13, 2024, 6:00 AM EST - 2 years ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Jan 21, 2024, 7:00 AM EST - 2 years ago

Onconetix Slides: Corporate presentation

Dec 19, 2023, 7:00 AM EST - 2 years ago

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Dec 18, 2023, 7:00 AM EST - 2 years ago

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Nov 2, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Nov 1, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Oct 30, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Issues Letter to Shareholders

Oct 10, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Aug 28, 2023, 4:30 PM EDT - 3 years ago

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Aug 3, 2023, 1:02 PM EDT - 3 years ago

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 1, 2023, 8:00 AM EDT - 3 years ago

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Jul 31, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Jul 25, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Jul 17, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Jul 11, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Jul 6, 2023, 5:05 PM EDT - 3 years ago

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Jul 6, 2023, 7:30 AM EDT - 3 years ago

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

Jun 28, 2023, 7:55 AM EDT - 3 years ago

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

drweinerdog1 Jul. 20 at 2:28 PM

$ONCO congrats everyone on another all time low

0 · Reply

drweinerdog1 Jul. 20 at 2:14 PM

$ONCO how much dilution this week

0 · Reply

Sarah147 Jul. 20 at 10:59 AM

$ONCO clean ticker

1 · Reply

URANIUM77 Jul. 20 at 9:44 AM

$ONCO There is no dilution The company still has only 3.69M shares https://dilutiontracker.com/app/search/ONCO

0 · Reply

drweinerdog1 Jul. 17 at 9:34 PM

$ONCO wow no dilution on a Friday, good job guys, you guys did so good.

0 · Reply

drweinerdog1 Jul. 17 at 3:51 PM

$ONCO the scam that keeps scamming

0 · Reply

URANIUM77 Jul. 17 at 1:48 PM

$ONCO If we get 10% of Realbotix, it equates to 10 times the current share price for us ONCO shareholders. Mega BULL

1 · Reply

URANIUM77 Jul. 17 at 12:41 PM

$ONCO 👊There are no real sellers left anymore. Only short positions remain in the free float. No one is giving away their shares anymore.💪

2 · Reply

URANIUM77 Jul. 17 at 8:33 AM

1 · Reply

drweinerdog1 Jul. 16 at 10:45 PM

$ONCO where did the other pumper go, or maybe he blocked me

0 · Reply

NEWBIGTECH Jul. 16 at 6:23 PM

$XBOTF $ONCO

1 · Reply

NEWBIGTECH Jul. 16 at 6:21 PM

$ONCO

0 · Reply

drweinerdog1 Jul. 16 at 5:40 PM

$ONCO getting close to that all time low, Days since daily all time low, currently 0

0 · Reply

drweinerdog1 Jul. 16 at 4:06 PM

$ONCO still waiting for what I made up?

0 · Reply

drweinerdog1 Jul. 16 at 4:05 PM

$ONCO noon, time to turn the printing presses on.

0 · Reply

URANIUM77 Jul. 16 at 3:35 PM

$ONCO The merger will multiply the value tenfold, and the products represent the future and will generate billions in value. I’m loading up and have faith in it—others can do as they please.

1 · Reply

URANIUM77 Jul. 16 at 2:56 PM

$ONCO Merger is coming soon now

1 · Reply

drweinerdog1 Jul. 16 at 1:32 PM

$ONCO going to be tough to get 12 m out of a stock with 2.6 mc. I am no math expert

0 · Reply

drweinerdog1 Jul. 15 at 10:28 PM

$ONCO 68k invested since my last averaged down at .8, it just doesn’t stop

0 · Reply

Siara1620 Jul. 15 at 9:57 PM

$ONCO 🤡

0 · Reply

bionicman1969 Jul. 15 at 7:43 PM

$ONCO not far from sub penny and another RS or delisting get out BK shell with massive debt and preferred and VS robo merger from Canada STRONG SELL

0 · Reply

drweinerdog1 Jul. 15 at 7:37 PM

$ONCO u can’t keep diluting a dead horse eventually you run out of other people’s money

1 · Reply

Market Cap	867,000.00
Revenue (ttm)	820,000.00
Net Income (ttm)	-14.03M
EPS (ttm)	N/A
PE Ratio	0.02
Forward PE	N/A
Profit Margin	-1,710.98%
Debt to Equity Ratio	0.00

Volume	78,800
Avg Vol	1,050,663
Day's Range	N/A - N/A
Shares Out	1.14M
Stochastic %K	3%
Beta	2.69
Analysts	Strong Buy
Price Target	N/A